Can video texts and mailed kits boost colon cancer screening?
NCT ID NCT06542835
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a combination of tools—video messages, mailed stool test kits, and help with social needs—to encourage colorectal cancer screening among Latinx adults aged 45-64. About 6000 participants will receive these supports, and researchers will compare screening completion rates before and after the intervention. The goal is to find effective ways to reduce screening gaps and counter misinformation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that culturally tailored video messages and support services significantly increase colorectal cancer screening rates in underserved Latinx populations.
- What could go wrong
- This is a behavioral intervention trial, not testing a new drug or cure. Success depends on participants' engagement, and results may not apply to other groups or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 6,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2024
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 64 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Ages 45-64 * Eligible for colorectal cancer (CRC) screening * Current patients (seen in the clinic in the last 6 months) * Primary speaker of English or Spanish * Cell phone listed in Electronic Health Record (EHR) * No recent history of CRC screening * Resides in one of the neighborhoods included in the main trial Exclusion Criteria: * Colorectal disease (e.g., ulcerative colitis or colectomy) * Personal history of colorectal cancer * End-stage or life-threatening diseases * Known to be under hospice care * Living in a skilled nursing facility * Patients who decline research participation will be removed from the patient contact list
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
AltaMed Health Services Corporation
RECRUITINGLos Angeles, California, 90040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?
- A 2.2 mm scope could spot cancerous tissue in minutes, not days
- The gatekeepers of tumors: scientists probe how blood vessels let immune cells in
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers